Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 6
Submit an article Journal homepage
224
Views
4
CrossRef citations to date
0
Altmetric
Letter

Case series of patients with acute myeloid leukemia receiving hypomethylation therapy and retrospectively found to have IDH1 or IDH2 mutations

Christopher B. BentonDivision of Cancer Medicine
,
Farhad RavandiDepartment of Leukemia
,
Michael AndreeffDepartment of Leukemia
,
Tapan KadiaDepartment of Leukemia
,
Vivian RuvoloDepartment of Leukemia
,
Peng QiuDepartment of Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
David A. WheelerHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
,
Guillermo Garcia-ManeroDepartment of Leukemia
,
Jorge CortesDepartment of Leukemia
,
Hagop M. KantarjianDepartment of Leukemia
&
Marina KonoplevaDepartment of LeukemiaCorrespondence[email protected]
 show all
Pages 1431-1434 | Received 08 May 2013, Accepted 28 Aug 2013, Published online: 01 Nov 2013

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Prajwal Boddu & Gautam Borthakur. (2017) Therapeutic targeting of isocitrate dehydrogenase mutant AML. Expert Opinion on Investigational Drugs 26:5, pages 525-530.
Read now
Johanna Mondesir, Christophe Willekens, Mehdi Touat & Stéphane de Botton. (2016) IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. Journal of Blood Medicine 7, pages 171-180.
Read now

Articles from other publishers (2)

Xiaoyan Liu & Yuping Gong. (2019) Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. Biomarker Research 7:1.
Crossref
Remco J. Molenaar, Tomas Radivoyevitch, Jaroslaw P. Maciejewski, Cornelis J.F. van Noorden & Fonnet E. Bleeker. (2014) The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 326-341.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.